Exploratory study to assess the biological activity of ZD6126 in subjects with newly diagnosed metastatic renal cell carcinoma (stage IV)
Phase of Trial: Phase II
Latest Information Update: 20 Sep 2005
At a glance
- Drugs ZD 6126 (Primary)
- Indications Renal cancer
- Focus Therapeutic Use
- 20 Sep 2005 New trial record.